Abel Hall, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2013339 BATON ROUGE, LA

Position in BMY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,196,594

-$83,121 QoQ

Shares Held

20,767

-1.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#1,068

of 2,506 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Abel Hall, LLC holds $16,989,938 across 13 Drug Manufacturers - General names. BMY ranks #5 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,675	$3,208,475
2	JNJ	Johnson & Johnson	9,158	$2,325,857
3	NVS	Novartis AG	14,598	$2,287,798
4	ABBV	AbbVie Inc.	7,378	$1,856,599
5	BMY	Bristol Myers Squibb Co This page	20,767	$1,196,594
6	MRK	Merck & Co., Inc.	7,789	$1,000,886
7	PFE	Pfizer Inc	40,621	$978,153
8	NVO	Novo Nordisk A S	19,198	$920,352

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,196,594	20,767	-1.6%	Shares	Sole	2026-07-24
2026-03-31	$1,279,715	21,100	+3.6%	Shares	Sole	2026-04-28
2025-12-31	$1,098,488	20,365	+70.6%	Shares	Sole	2026-02-17
2025-09-30	$538,313	11,936	+24.4%	Shares	Sole	2025-11-17
2025-06-30	$444,198	9,596	-41.2%	Shares	Sole	2025-07-23
2025-03-31	$995,539	16,323	-8.0%	Shares	Sole	2025-05-06
2024-12-31	$1,003,544	17,743	+2.0%	Shares	Sole	2025-01-23
2024-09-30	$900,379	17,402	+42.0%	Shares	Sole	2024-11-15
2024-06-30	$509,116	12,259	+24.5%	Shares	Sole	2024-07-25
2024-03-31	$534,002	9,847	+130.3%	Shares	Sole	2024-05-08
2023-12-31	$219,401	4,276	—	Shares	Sole	2024-02-28
No filing history on record for this holder in this stock.